Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT01355484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III, Randomized, Double-Blind, Placebo Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer on First Line Platinum Plus a Taxane Chemotherapy
Study identification
- NCT ID
- NCT01355484
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GTx
- Industry
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Interventions
- GTx-024 Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- Apr 30, 2013
- Completion
- May 31, 2014
- Last update posted
- Mar 2, 2016
2011 – 2014
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GTx Investigative Site | Birmingham | Alabama | 35211 | — |
| GTx Investigative Site | Long Beach | California | 90813 | — |
| GTx Investigative Site | Aventura | Florida | 33180 | — |
| GTx Investigative Site | Miami | Florida | 33133 | — |
| GTx Investigative Site | Orange City | Florida | 32763 | — |
| GTx Investigative Site | Tampa | Florida | 33612 | — |
| GTx Investigative Site | Decatur | Illinois | 62526 | — |
| GTx Investigative Site | Peoria | Illinois | 61615 | — |
| GTx Investigative Site | Skokie | Illinois | 60076 | — |
| GTx Investigative Site | Indianapolis | Indiana | 46260 | — |
| GTx Investigative Site | Ashland | Kentucky | 41101 | — |
| GTx Investigative Site | Concord | Massachusetts | 01742 | — |
| GTx Investigative Site | Saint Clair Shores | Michigan | 48081 | — |
| GTx Investigative Site | Tupelo | Mississippi | 38801 | — |
| GTx Investigative Site | Great Falls | Montana | 59405 | — |
| GTx Investigative Site | Rochester | New York | 14642 | — |
| GTx Investigative Site | Burlington | North Carolina | 27215 | — |
| GTx Investigative Site | Flat Rock | North Carolina | 28731 | — |
| GTx Investigative Site | Wilmington | North Carolina | 28401 | — |
| GTx Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| GTx Investigative Site | Canfield | Ohio | 44406 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| GTx Investigative Site | Sandusky | Ohio | 44870 | — |
| GTx Investigative Site | Portland | Oregon | 97213 | — |
| GTx Investigative Site | Lancaster | Pennsylvania | 17604 | — |
| GTx Investigative Site | Spartanburg | South Carolina | 29303 | — |
| GTx Investigative Site | Round Rock | Texas | 78665 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01355484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01355484 live on ClinicalTrials.gov.